SMARCA2 and cancer: Hence, Brg1 and/or Brm loss appears to foster multiple facets of cancer development via an overall change in the cellular gene expression profile that favors the expression of tumor progression genes and the concomitant reduction in the expression of genes that block or thwart cancer development.